期刊文献+

运用证素辨证理论探讨多发性硬化中医分型思路 被引量:2

下载PDF
导出
摘要 多发性硬化(multiple sclerosis,MS)是一种免疫介导的中枢神经系统慢性炎性脱髓鞘性疾病,其病因尚不明确,可能与遗传、环境因素、病毒感染及自身免疫等相关。目前本病中医分型缺乏统一、公认、客观的标准,所涉及证型多而繁杂,治疗也各有侧重。由朱文锋教授创立并提出的证素辨证理论在继承中医传统辨证理论的基础上,较之于目前多发性硬化的中医分型方法颇具优势。以证素为核心的辨证体系,使辨证方法较容易掌握,大大提高了辨证的准确性和规范性。
作者 胡蕊 樊永平
出处 《江苏中医药》 CAS 2011年第8期1-2,共2页 Jiangsu Journal of Traditional Chinese Medicine
基金 首都医学发展基金资助项目(2005-SF-Ⅰ-001)
  • 相关文献

参考文献8

二级参考文献64

  • 1Tintoré M,Rovira A,Rio J,et al.Baseline MRI predicts future attacks and disability in clinically isolated syndromes.Neurology,2006,67:968-972.
  • 2Beck RW,Trobe JD,Moke PS,et al.High-and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis:experience of the optic neuritis treatment trial.Arch Ophthalmol,2003.121:944-949.
  • 3CHAMPS Study Group.MRI predictors of early conversion to clinically definite MS in the CHAMPS placebo group.Neurology,2002,59:998-1005.
  • 4Confavreux C,Vukusic S,Adeleine P.Early clinical predictors and progression of irreversible disability in multiple sclerosis:an amnesic process.Brain,2003,126:770-782.
  • 5Mianeboo A,Barkhof F,Polman CH,et al.Infratentorial lesions predict long-term disability in patients with initial findings suggestive of multiple sclerosis.Arch Neurol,2004,61:217-221.
  • 6Chard DT,Brex PA,Cicearelli O,et al.Thelongitudinal relation between brain lesion load and atrophy in multiple sclerosis:a 14 year follow-up study.J Neurol Neurosurg Psychiatr,2003,74:1551-1554.
  • 7Weinshenker BG,Bass B,Rice GP,et al.The natural history of multiple sclerosis:a geographically based study.Ⅰ.Clinical course and disability.Brain,1989,112:133-146.
  • 8Weinshenker BG,Bass B,Rice GP,et al.The natural history of multiple sclerosis:a geographically based study.Ⅱ.Predictive value of the early clinical course.Brain,1989.112:1419-1428.
  • 9Compston DA.McAlpine's multiple sclerosis.4th ed.New York:Churchill Livingstone,2006.
  • 10Lublin FD,Reingold SC.Defining the clinical course of multiple sclerosis:results of an international survey.National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis.Neurology,1996,46:907-911.

共引文献143

同被引文献48

引证文献2

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部